시장보고서
상품코드
2035872

화학단백체학 시장 보고서(2026년)

Chemoproteomics Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,795,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,822,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,849,000
카드담기
※ 부가세 별도
한글목차
영문목차

화학단백체학 시장 규모는 최근 급성장하고 있습니다. 2025년 17억 7,000만 달러에서 2026년에는 20억 1,000만 달러로, CAGR 13.5%로 성장할 전망입니다. 지난 수년간의 성장은 단백질체학 연구에 대한 투자 증가, 제약 분야의 R&D 활동 확대, 첨단 질량 분석 기술 도입, 신약 개발 및 바이오마커 식별을 위한 노력의 활성화, 그리고 학술 및 연구 기관의 확대에 기인하는 것으로 보입니다.

화학단백체학 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. CAGR 13.7%로 확대되어 2030년에는 33억 6,000만 달러에 이를 것으로 예측됩니다. 예측 기간 동안의 성장은 단백질체학 분석에 대한 AI의 통합, 고처리량 화학단백체학 플랫폼에 대한 수요 증가, 맞춤의료에 대한 관심 증가, CRO(임상시험수탁기관)의 확대, 멀티오믹스 접근법의 채택 증가 등에 기인한 것으로 분석됩니다. 멀티오믹스 접근법의 채택이 증가하고 있기 때문인 것으로 분석됩니다. 예측 기간의 주요 동향으로는 활성 기반 단백질 프로파일링의 채택 확대, 정량적 단백질체학 기술에 대한 수요 증가, 구조적 단백질체학 기법의 통합 발전, 친화도 기반 단백질 프로파일링의 적용 확대, 무표지 및 동위원소 표지 기술에 대한 관심 증가 등을 들 수 있습니다. 등을 들 수 있습니다.

맞춤형 의료에 대한 수요 증가는 가까운 미래에 화학단백체학 시장의 성장을 가속화할 것으로 예측됩니다. 맞춤의료는 환자의 유전자 구성, 바이오마커, 고유한 질병 특성에 따라 환자 개개인에 맞는 맞춤형 의료 및 치료법을 말합니다. 유전체 기술과 분자진단의 발전으로 의사가 환자의 유전자 프로파일에 맞는 치료법을 설계하고 치료 효과를 높일 수 있게 되면서 맞춤형 의료에 대한 수요가 확대되고 있습니다. 화학단백체학는 환자별 단백질-약물 상호작용 및 바이오마커 패턴을 검출하여 맞춤형 의료를 지원하고, 부작용을 줄이면서 효능을 최적화하는 표적 치료를 촉진합니다. 예를 들어, 미국 비영리단체 'Personalized Medicine Coalition'에 따르면, 2024년 2월 기준 미국 식품의약국(FDA)은 2023년 희귀질환 환자를 위한 16개의 새로운 개인 맞춤형 치료제를 승인했습니다. 이는 2022년 6건에서 증가한 것으로, 그 내역은 암치료제가 7건, 기타 질환 및 병태생리용이 3건입니다. 따라서 맞춤형 의료에 대한 수요가 증가하면서 화학단백체학 시장의 성장을 견인하고 있습니다.

화학단백체학 시장에서 사업을 전개하는 주요 기업들은 신약개발을 가속화하고 초기 단계의 유효성 예측 정확도를 높이기 위해 생세포 타겟팅 플랫폼과 같은 혁신적인 솔루션 개발에 집중하고 있습니다. 생세포 표적 관여 플랫폼은 생세포 내에서 약물 후보물질이 분자 표적과 어떻게 상호작용하는지를 실시간으로 측정하는 기술로, 기존 in vitro assay보다 더 정확하고 생리적 연관성이 높은 데이터를 제공합니다. 예를 들어, 2025년 9월 미국 기반의 생명공학 연구 기업인 LeadArt Biotechnologies Inc.는 AHeDD 2025에서 차세대 생세포 표적 참여 및 화학단백질체학 시스템인 INTRAP 플랫폼을 발표하였습니다. 이 플랫폼은 화학단백질체학, 자동화, AI를 통합하여 살아있는 세포 내에서 직접 약물과 표적의 상호작용을 분석합니다. 이를 통해 연구자들은 특히 난치성 또는 '신약개발이 어려운' 표적에 대해 보다 효율적으로 약물 후보물질을 발굴하고 최적화할 수 있습니다. INTRAP은 실시간으로 생리적 연관성이 높은 데이터를 제공함으로써 초기 단계의 성공률을 높이고, 전체 신약개발 과정을 가속화하는 것을 목표로 하고 있습니다.

자주 묻는 질문

  • 화학단백체학 시장 규모는 어떻게 변화하고 있나요?
  • 화학단백체학 시장의 성장은 어떤 요인에 기인하나요?
  • 맞춤형 의료에 대한 수요 증가는 화학단백체학 시장에 어떤 영향을 미치나요?
  • 화학단백체학 시장에서 주요 기업들은 어떤 혁신적인 솔루션을 개발하고 있나요?
  • INTRAP 플랫폼은 어떤 기능을 가지고 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 시장 분석 : 최종 이용 산업별

제6장 시장 거시경제 시나리오(금리, 인플레이션, 지정학, 무역 전쟁, 관세 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향 포함)

제7장 세계 시장 전략 분석 프레임워크, 현재 시장 규모, 시장 비교, 성장률 분석

제8장 세계의 총잠재 시장 규모(TAM) 분석

제9장 시장 구분

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 : 경쟁 벤치마킹과 대시보드

제39장 시장에 진입 예정 스타트업

제40장 주요 기업인수합병(M&A)

제41장 시장 잠재력 높은 국가 및 부문과 전략

제42장 부록

JHS 26.05.20

Chemoproteomics is a field within proteomics that employs chemical probes to systematically investigate protein interactions, functions, and modifications in complex biological systems. It facilitates the identification of drug targets, protein-ligand interactions, and the mapping of reactive sites across the proteome.

The primary technologies of chemoproteomics include activity-based protein profiling, quantitative proteomics, structural proteomics, affinity-based protein profiling, and label-free and isotope labeling techniques. Activity-based protein profiling (ABPP) uses chemical probes to selectively label and measure the functional activity of enzymes in complex biological samples. Product types include reagents and kits, instruments, software, and services. Applications include drug discovery, target identification and validation, biomarker discovery, proteome profiling, and other uses, while end users include pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end-users.

Tariffs on imported reagents, laboratory instruments, and analytical software are impacting the chemoproteomics market by increasing costs for instrument-intensive techniques and consumables, particularly affecting segments such as activity-based protein profiling and structural proteomics. Regions such as North America, Europe, and Asia-Pacific that rely heavily on imported high-end mass spectrometry instruments and reagents are most affected. While tariffs raise costs, they also encourage local manufacturing, development of domestic analytical platforms, and innovation in cost-efficient, high-throughput proteomics solutions, providing strategic opportunities for regional market players.

The chemoproteomics market research report is one of a series of new reports from The Business Research Company that provides chemoproteomics market statistics, including chemoproteomics industry global market size, regional shares, competitors with a chemoproteomics market share, detailed chemoproteomics market segments, market trends and opportunities, and any further data you may need to thrive in the chemoproteomics industry. This chemoproteomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chemoproteomics market size has grown rapidly in recent years. It will grow from $1.77 billion in 2025 to $2.01 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing investment in proteomics research, growing pharmaceutical R&D activities, adoption of advanced mass spectrometry techniques, rising drug discovery and biomarker identification efforts, expansion of academic and research institutes.

The chemoproteomics market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to growing integration of AI in proteomics analysis, increasing demand for high-throughput chemoproteomics platforms, rising focus on personalized medicine, expansion of contract research organizations, increasing adoption of multi-omics approaches. Major trends in the forecast period include increasing adoption of activity-based protein profiling, rising demand for quantitative proteomics techniques, growing integration of structural proteomics approaches, expansion of affinity-based protein profiling applications, rising focus on label-free and isotope labeling techniques.

The rising demand for personalized medicine is projected to accelerate the growth of the chemoproteomics market in the foreseeable future. Personalized medicine involves medical treatments and therapies customized for individual patients based on their genetic composition, biomarkers, and unique disease characteristics. The demand for personalized medicine is expanding due to progress in genomic technologies and molecular diagnostics, which enable physicians to design treatments tailored to a patient's genetic profile and enhance therapeutic effectiveness. Chemoproteomics supports personalized medicine by detecting patient-specific protein-drug interactions and biomarker patterns, facilitating targeted therapies that optimize efficacy while reducing adverse effects. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration authorized 16 new personalized therapies for rare disease patients in 2023, compared to six in 2022, including seven oncology drugs and three for other diseases and conditions. Therefore, the increasing demand for personalized medicine is propelling the growth of the chemoproteomics market.

Key companies operating in the chemoproteomics market are focusing on developing innovative solutions such as live cell target engagement platforms to accelerate drug discovery and improve early stage efficacy prediction. A live cell target engagement platform is a technology that measures how drug candidates interact with their molecular targets inside living cells in real time, providing more accurate and physiologically relevant data than traditional in vitro assays. For example, in September 2025, LeadArt Biotechnologies Inc., a US-based biotechnology research company, launched its INTRAP platform, a next-generation live-cell target engagement and chemoproteomics system, at AHeDD 2025. The platform integrates chemoproteomics, automation, and AI to analyze drug-target interactions directly within living cells. This enables researchers to identify and optimize drug candidates more efficiently, particularly for challenging or "undruggable" targets. By providing real-time, physiologically relevant data, INTRAP aims to improve early-stage success rates and accelerate the overall drug discovery process.

In March 2025, Momentum Biotechnologies, a US-based biotechnology company, acquired OmicScouts for an undisclosed amount. Through this transaction, Momentum Biotechnologies intends to strengthen its technological expertise in multi-omics data analytics and speed up its drug discovery and development processes. OmicScouts GmbH is a Germany-based biotechnology company that focuses on delivering comprehensive chemoproteomics services for drug discovery, with an emphasis on target identification, selectivity profiling, and mechanism-of-action research.

Major companies operating in the chemoproteomics market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies Inc., Shimadzu Corporation, PerkinElmer Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Evotec SE, Promega Corporation, Cell Signaling Technology Inc., Seer Inc., ChomiX Biotech Inc., Abcam plc, Creative Proteomics Inc., MtoZ Biolabs Inc., Allumiqs Corporation, Dalriada Drug Discovery Ltd., MS Bioworks LLC.

North America was the largest region in the chemoproteomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemoproteomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chemoproteomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chemoproteomics market consists of revenues earned by entities by providing services such as target identification and validation, protein-ligand interaction profiling, activity-based protein profiling, biomarker discovery and validation, and quantitative proteomics and chemoproteomic data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemoproteomics market also includes sales of mass spectrometry instruments, liquid chromatography systems, bioinformatics and data analysis software, consumables and reagents, and automated sample preparation hardware. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chemoproteomics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses chemoproteomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chemoproteomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemoproteomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Activity Based Protein Profiling; Quantitative Proteomics; Structural Proteomics; Affinity Based Protein Profiling; Label Free And Isotope Labeling Techniques
  • 2) By Product Type: Reagents And Kits; Instruments; Software; Services
  • 3) By Application: Drug Discovery; Target Identification And Validation; Biomarker Discovery; Proteome Profiling; Other Application
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End-User
  • Subsegments:
  • 1) By Activity Based Protein Profiling: Enzyme Activity Profiling; Covalent Probe Profiling; Targeted Activity Profiling; Functional Protein Profiling
  • 2) By Quantitative Proteomics: Stable Isotope Labeling; Isobaric Tag Labeling; Label Free Quantification; Metabolic Labeling
  • 3) By Structural Proteomics: X Ray Crystallography; Nuclear Magnetic Resonance; Cryogenic Electron Microscopy; Hydrogen Deuterium Exchange
  • 4) By Affinity Based Protein Profiling: Protein Ligand Interaction; Antibody Based Capture; Small Molecule Affinity Capture; Protein Complex Isolation
  • 5) By Label Free and Isotope Labeling Techniques: Label Free Mass Spectrometry; Isotope Coded Affinity Tagging; Dimethyl Labeling; Tandem Mass Tag Labeling
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Agilent Technologies Inc.; Shimadzu Corporation; PerkinElmer Inc.; Bruker Corporation; Waters Corporation; Bio-Rad Laboratories Inc.; Evotec SE; Promega Corporation; Cell Signaling Technology Inc.; Seer Inc.; ChomiX Biotech Inc.; Abcam plc; Creative Proteomics Inc.; MtoZ Biolabs Inc.; Allumiqs Corporation; Dalriada Drug Discovery Ltd.; MS Bioworks LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Chemoproteomics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Chemoproteomics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Chemoproteomics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Chemoproteomics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Activity-Based Protein Profiling
    • 4.2.2 Rising Demand for Quantitative Proteomics Techniques
    • 4.2.3 Growing Integration of Structural Proteomics Approaches
    • 4.2.4 Expansion of Affinity-Based Protein Profiling Applications
    • 4.2.5 Rising Focus on Label-Free and Isotope Labeling Techniques

5. Chemoproteomics Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Companies
  • 5.2 Academic And Research Institutes
  • 5.3 Contract Research Organizations
  • 5.4 Clinical Research Laboratories
  • 5.5 Government Research Institutes

6. Chemoproteomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chemoproteomics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Chemoproteomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Chemoproteomics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Chemoproteomics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Chemoproteomics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chemoproteomics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chemoproteomics Market Segmentation

  • 9.1. Global Chemoproteomics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Activity Based Protein Profiling, Quantitative Proteomics, Structural Proteomics, Affinity Based Protein Profiling, Label Free And Isotope Labeling Techniques
  • 9.2. Global Chemoproteomics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Instruments, Software, Services
  • 9.3. Global Chemoproteomics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery, Target Identification And Validation, Biomarker Discovery, Proteome Profiling, Other Application
  • 9.4. Global Chemoproteomics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-User
  • 9.5. Global Chemoproteomics Market, Sub-Segmentation Of Activity Based Protein Profiling, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme Activity Profiling, Covalent Probe Profiling, Targeted Activity Profiling, Functional Protein Profiling
  • 9.6. Global Chemoproteomics Market, Sub-Segmentation Of Quantitative Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stable Isotope Labeling, Isobaric Tag Labeling, Label Free Quantification, Metabolic Labeling
  • 9.7. Global Chemoproteomics Market, Sub-Segmentation Of Structural Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • X Ray Crystallography, Nuclear Magnetic Resonance, Cryogenic Electron Microscopy, Hydrogen Deuterium Exchange
  • 9.8. Global Chemoproteomics Market, Sub-Segmentation Of Affinity Based Protein Profiling, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Protein Ligand Interaction, Antibody Based Capture, Small Molecule Affinity Capture, Protein Complex Isolation
  • 9.9. Global Chemoproteomics Market, Sub-Segmentation Of Label Free And Isotope Labeling Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Label Free Mass Spectrometry, Isotope Coded Affinity Tagging, Dimethyl Labeling, Tandem Mass Tag Labeling

10. Chemoproteomics Market Regional And Country Analysis

  • 10.1. Global Chemoproteomics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Chemoproteomics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chemoproteomics Market

  • 11.1. Asia-Pacific Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chemoproteomics Market

  • 12.1. China Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chemoproteomics Market

  • 13.1. India Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chemoproteomics Market

  • 14.1. Japan Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chemoproteomics Market

  • 15.1. Australia Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chemoproteomics Market

  • 16.1. Indonesia Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chemoproteomics Market

  • 17.1. South Korea Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chemoproteomics Market

  • 18.1. Taiwan Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chemoproteomics Market

  • 19.1. South East Asia Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chemoproteomics Market

  • 20.1. Western Europe Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chemoproteomics Market

  • 21.1. UK Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chemoproteomics Market

  • 22.1. Germany Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chemoproteomics Market

  • 23.1. France Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chemoproteomics Market

  • 24.1. Italy Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chemoproteomics Market

  • 25.1. Spain Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chemoproteomics Market

  • 26.1. Eastern Europe Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chemoproteomics Market

  • 27.1. Russia Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chemoproteomics Market

  • 28.1. North America Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chemoproteomics Market

  • 29.1. USA Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chemoproteomics Market

  • 30.1. Canada Chemoproteomics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chemoproteomics Market

  • 31.1. South America Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chemoproteomics Market

  • 32.1. Brazil Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chemoproteomics Market

  • 33.1. Middle East Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chemoproteomics Market

  • 34.1. Africa Chemoproteomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Chemoproteomics Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chemoproteomics Market Regulatory and Investment Landscape

36. Chemoproteomics Market Competitive Landscape And Company Profiles

  • 36.1. Chemoproteomics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Chemoproteomics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Chemoproteomics Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Shimadzu Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Chemoproteomics Market Other Major And Innovative Companies

  • PerkinElmer Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Evotec SE, Promega Corporation, Cell Signaling Technology Inc., Seer Inc., ChomiX Biotech Inc., Abcam plc, Creative Proteomics Inc., MtoZ Biolabs Inc., Allumiqs Corporation, Dalriada Drug Discovery Ltd., MS Bioworks LLC

38. Global Chemoproteomics Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Chemoproteomics Market

41. Chemoproteomics Market High Potential Countries, Segments and Strategies

  • 41.1 Chemoproteomics Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Chemoproteomics Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Chemoproteomics Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기